Breaking News, Collaborations & Alliances

Lonza Joins GENEGUT Project to Develop Capsule Delivery Solution

Four-year project aims to develop an innovative Crohn's disease treatment based on RNA and targeted delivery.

Author Image

By: Charlie Sternberg

Associate Editor

Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, has joined the GENEGUT project to develop an innovative functional capsule-based delivery solution for therapies targeting ileal Crohn’s disease (CD), which currently affects up to three million people in Europe, resulting in annual health costs of over 5 billion euros.     The four-year research project, funded by Horizon Europe, aims to develop the first non-invasive oral RNA-based th...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters